Ipsen
Ipsen is a mid-sized global biopharmaceutical company focused on transformative medicines in Oncology, Rare Disease, and Neuroscience. The company emphasizes human-centric leadership, collaboration, and innovation to address high unmet medical needs, aiming to create a positive impact on patients and society.
Headquarters
Paris, Île-De-France, France
Company Size
5001-10000 employees
Founded
1929
Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ipsen.
Ipsen didn’t post a salary, so this is our estimate from similar listings.
IPSEN (OTCMKTS:IPSEY) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened
9 hours ago
Chief of Staff to CEO of BridgeBio and GondolaBio
BridgeBio Pharma
Senior Director, IL Commercial Operations
USAJOBS
Manager - Commercial Analytics
BridgeBio Pharma
(CW) Contract Associate/Document Control Records Management
biomarin
Treasury Manager
biomarin
Regional Business Director – Southeast Region
SpringWorks Therapeutics